LGALS3 and Hyperglycemia: In agreement, the increased circulating levels of Gal-3 observed in patients with Type 2 Diabetes are negatively correlated with glycated hemoglobin (HbA1c), suggesting a possible protective role for Gal-3 in the setting of hyperglycemia [10].